Osteoporosis in traumatology. Prevalence and management;Osteoporose in der unfallchirurgie. Prävalenz und management

Unfallchirurg

Volumn 108, Issue 5, 2005, Pages 356-364

  Vogel, T ^a   Dobler, T ^a   Bitterling, H ^a   Biberthaler, P ^a   Kanz, K G ^a   Pfeifer, K J ^a   Bartl, R ^a   Mutschler, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Algorithm; Fracture; Osteoporosis; Therapy; Trauma orthopedic surgery

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BONE DENSITY; BONE INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDY; SURGEON; TIME SERIES ANALYSIS; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ALGORITHMS; BONE DENSITY; COMORBIDITY; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 21644457186     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-005-0927-y     Document Type: Article

References (35)

1. Bartl R (2001) Osteoporose - Prävention, Diagnostik, Therapie. Thieme, Stuttgart New York
2. Bartl R, Bartl C, Mutschler W (2003) Diagnostik und Therapie der Osteoporose. Unfallchirurg 106: 526-541
3. Black DM, Thompson DE, Bauer D et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial. Osteoporos Int 85: 4118-4124
4. Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535-1541
5. Black DM, Nevitt MC, Palermo L (1994) Prediction of new vertebral deformities. J Bone Miner Res 9 [Suppl]: 135
6. Bone HG, Hosking D, Devogelaer J-P et al. (2004) Ten years, experience with alendronate for osteoporosis in postmenopausal women. N Eng J Med 350: 1189-1199
7. Cuddihy MT, Gabriel SE, Crowson CS et al. (2002) Osteoporosis intervention following distal forearm fractures: A missed opportunity? Arch Intern Med 162: 421-426
8. Cummings SR, Black DM, Rubin SM (1989) Liftime risks of hip, Colle,s, or vertebral fracture and heart desease among white postmenopausal women. Arch Intern Med 149: 2445-2448
9. Cummings SR, Nevitt MC, Browner WS (1995) Rise factors for hip fracture in white women. N Eng J Med 332: 767-773
10. Dawson-Huges B, Harris SS, Krall EA et al. (1997) Effect of Calcium and Vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337: 670-676
11. Feldstein A, Elmer PJ, Orwoll E et al. (2004) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures. Arch Intern Med 163: 2156-2171
12. Follin SL, Black JN, McDermott MT (2003) Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 23: 190-198
13. Freedman KB, Kaplan FS, Bilker WB et al. (2000) Treatment of osteoporosis: Are physicians missing an opportunity? J Bone Joint Surg Am 82: 1063-1070
14. Götte S, Dittmar K (2001) Epidemiologie und Kosten der Osteoporose. Orthopäde 30: 402-404
15. Hanley DA, Josse RG (1996) Prevention and management of osteoporosis: consensus Statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. CMAJ 155: 921-923
16. Johnell O, Kanis JA, Oden A et al. (2004) Fractrure rise following an osteoporotc fracture. Osteoporos Int 15: 175-179
17. Jones G, Nguyen T, Sambrook PN et al. (1994) Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 4: 277-282
18. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109: 326-328
19. Kaufman JD, Bolander ME, Bunta AD et al. (2003) Barriers and solutions to osteoporosis care in patients with a hip fracture. J Bone Joint Surg Am 85: 1837-1843
20. Lauritzen JB, Schwarz P, Lund B et al. (1993) Changing incidence and residual liftime risk of common osteoporosis-related fractures. Osteoporos Int 3: 127-132
21. Leitlinien des DVO (2003-2004) Leitlinien des deutschsprachigen Dachverbandes für Osteologie (DVO) zur Osteoporose. http://www.dv- osteologie. org
22. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312: 1254-1259
23. McLellan AR, Gallacher J, Fraser M et al. (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14: 1028-1034
24. National Osteoporosis Foundation (1998) Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int 8 [Suppl 4]: 1-88
25. Obernender PO, Fritschi DA (2003) Versorgungsmängel bei einer relevanten Frauenkrankheit. Dtsch Ärtztebl 25: 1728-1731
26. Reginster JY, Minne HW, Sorensen OH et al. (2000) Randomized trial of the effect of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11: 83-91
27. Ross PD (1996) Osteoporosis: frequency, consequences, and risk factors. Arch Intern Med 156: 1399-1411
28. Ross PD, Davis JW, Epstein RS (1991) Pre-existing fractures and bone mass predict vertebral fracture in women. Ann Intern Med 114: 919-923
29. Ross PD, Genant HK, Davis JW (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among nonblack, osteoporotic women. Osteoporos Int 3: 120-127
30. Simon JA, Lewiecki EM, Smith ME et al. (2002) Patient preference for once-weekly alendronate 70 mg versus once-dayly alendronate 10 mg: A multicenter randomized, open-label, crossover study. Clin Ther 24: 1871-1886
31. Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77: 334-338
32. Siris E, Adachi JD, Lu Y et al. (2002) Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple outcomes of Raloxifene evaluation. Osteoporos Int 13: 907-913
33. Smith MD, Ross W, Ahern MJ (2001) Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip an wrist fractures. J Rheumatol 28: 2504-2508
34. Warming L, Hassager C, Christiansen C (2002) Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 13: 105-112
35. World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series. WHO, Genf